Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis

Phase 2/3 Completed 9 enrolled Innovaderm Research Inc. Tribute Pharmaceuticals · collab

NaSingle-groupOpen-labelTreatment

Summary

This pilot, phase II, 24-week study will recruit a total of 10 patients and will evaluate the efficacy and safety of acitretin in patients with severe chronic hand dermatitis .

Timeline

Start: 2012-03
Primary completion: 2014-01
Completion: 2014-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acitretin	Small molecule	30 mg	Oral

Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis

Summary

Timeline

Drugs

Indications